Green Health Biotech Co., Ltd. (hereinafter referred to as "the Company" or "Green Health Biotech") announces that the 2025 Annual Shareholders' Meeting was held on March 31, 2026, at the first conference room on the second floor of the Company's comprehensive office building located at No. 6, Yuanzone Avenue, Pucheng County, Fujian Province. The meeting was conducted through a combination of on-site and online voting. A total of 99 shareholders and representatives attended the meeting, representing 76,039,481 shares, accounting for 48.9265% of the total shares of the Company. Among them, 10 shareholders and representatives attended the meeting on-site, representing 68,584,237 shares (44.1295% of total shares); 89 shareholders attended the meeting via online voting, representing 7,455,244 shares (4.7970% of total shares). The meeting was convened by the Company's board of directors. Due to business commitments, Chairman Wang Zuan was unable to attend the meeting in person and participated online. The meeting was presided over by Director Yang Jing, who was jointly nominated by more than half of the Company's directors. Company directors, the board secretary, and senior management attended the meeting, and lawyers from Fujian Jianda Law Firm witnessed the meeting. The convening and holding of this meeting complied with relevant laws, regulations, and the Company's Articles of Association.
I. Meeting Attendance and Voting Situation
1. Related Shareholder Situation
Shareholders with related interests who needed to abstain from voting and their relationships are as follows:
- Fujian Zongteng Network Co., Ltd. (hereinafter referred to as "Zongteng Network") is controlled by Chairman Wang Zuan and is the legal entity directly controlling the listed company. Zongteng Network has a related relationship with the Company as defined in the Shenzhen Stock Exchange Listing Rules. Zongteng Network abstained from voting on Proposal 5 "Proposal to Confirm the Director Remuneration for 2025 and the Director Remuneration Plan for 2026" and Proposal 9 "Proposal to Formulate the <Director and Senior Management Remuneration Management System>". The number of voting shares held by the related shareholder is 46,608,397 shares (as of the share registration date), abstaining from voting on Proposals 5 and 9. Shareholder Bao Zhongshou, a senior executive of the Company, has a related relationship with the Company as defined in the Shenzhen Stock Exchange Listing Rules and needed to abstain from voting on Proposal 9 "Proposal to Formulate the <Director and Senior Management Remuneration Management System>". The number of voting shares held by this related shareholder is 109,425 shares (as of the share registration date), abstaining from voting on Proposal 9.